Stocks and Investing Stocks and Investing
Thu, September 28, 2023
[ 12:00 AM ] - WOPRAI
Clarke Jeffries Reiterated (SPT) at Buy and Held Target at $56 on, Sep 28th, 2023
[ 12:00 AM ] - WOPRAI
Brett Knoblauch Maintained (SPT) at Hold with Increased Target to $48 on, Sep 28th, 2023
[ 12:00 AM ] - WOPRAI
Scott Deuschle Initiated (SPR) at Hold and Held Target at $16 on, Sep 28th, 2023
[ 12:00 AM ] - WOPRAI
Brian White Downgraded (SPOT) to Hold on, Sep 28th, 2023
[ 12:00 AM ] - WOPRAI
Eve Burstein Initiated (TMO) at Buy and Held Target at $603 on, Sep 28th, 2023
[ 12:00 AM ] - WOPRAI
Steve Barger Downgraded (TEX) to Hold on, Sep 28th, 2023
[ 12:00 AM ] - WOPRAI
Chirag Ved Initiated (TDC) at Buy and Held Target at $65 on, Sep 28th, 2023
[ 12:00 AM ] - WOPRAI
Scott Deuschle Initiated (TDG) at Strong Buy on, Sep 28th, 2023
Wed, September 27, 2023
[ 12:00 AM ] - WOPRAI
Robert Jamieson Initiated (TDY) at Strong Buy and Held Target at $495 on, Sep 27th, 2023
[ 12:00 AM ] - WOPRAI
Bill Chappell Maintained (TCBI) at Strong Buy with Decreased Target to $68 on, Sep 27th, 2023
[ 12:00 AM ] - WOPRAI
Lucas Pipes Maintained (TECK) at Strong Buy with Increased Target to $78 on, Sep 27th, 2023
[ 12:00 AM ] - WOPRAI
Brandt Montour Maintained (TNL) at Hold with Decreased Target to $38 on, Sep 27th, 2023
[ 12:00 AM ] - WOPRAI
Eric Handler Maintained (TKO) at Strong Buy with Decreased Target to $112 on, Sep 27th, 2023
[ 12:00 AM ] - WOPRAI
Nehal Chokshi Upgraded (TLS) to Buy and Held Target at $4 on, Sep 27th, 2023
[ 12:00 AM ] - WOPRAI
Mark Zgutowicz Reiterated (SPOT) at Strong Buy and Held Target at $205 on, Sep 27th, 2023
[ 12:00 AM ] - WOPRAI
Brandon King Downgraded (SSB) to Hold and Decreased Target to $73 on, Sep 27th, 2023
[ 12:00 AM ] - WOPRAI
Gil Luria Initiated (SOUN) at Strong Buy and Held Target at $5 on, Sep 27th, 2023
[ 12:00 AM ] - WOPRAI
Tim Long Maintained (SNX) at Hold with Increased Target to $99 on, Sep 27th, 2023
[ 12:00 AM ] - WOPRAI
Michael Ng Maintained (SNX) at Strong Buy with Increased Target to $112 on, Sep 27th, 2023
[ 12:00 AM ] - WOPRAI
Joseph Cardoso Maintained (SNX) at Buy with Decreased Target to $112 on, Sep 27th, 2023
[ 12:00 AM ] - WOPRAI
Ashish Sabadra Reiterated (SNX) at Hold and Held Target at $97 on, Sep 27th, 2023
[ 12:00 AM ] - WOPRAI
Manan Gosalia Maintained (SNV) at Hold with Decreased Target to $29 on, Sep 27th, 2023
[ 12:00 AM ] - WOPRAI
Jennifer Demba Maintained (SNV) at Strong Buy with Decreased Target to $31 on, Sep 27th, 2023
[ 12:00 AM ] - WOPRAI
Manan Gosalia Maintained (CFR) at Hold with Decreased Target to $109 on, Sep 27th, 2023
[ 12:00 AM ] - WOPRAI
Brandon King Maintained (CFR) at Hold with Decreased Target to $97 on, Sep 27th, 2023
[ 12:00 AM ] - WOPRAI
Philip Cusick Maintained (CCI) at Hold with Decreased Target to $112 on, Sep 27th, 2023
[ 12:00 AM ] - WOPRAI
Brandt Montour Maintained (VAC) at Buy with Decreased Target to $118 on, Sep 27th, 2023
[ 12:00 AM ] - WOPRAI
Edward White Reiterated (VALN) at Strong Buy and Held Target at $22 on, Sep 27th, 2023
[ 12:00 AM ] - WOPRAI
Yi Chen Reiterated (VERU) at Strong Buy and Held Target at $2 on, Sep 27th, 2023
[ 12:00 AM ] - WOPRAI
Ed Arce Reiterated (AKBA) at Strong Buy and Held Target at $3.75 on, Sep 27th, 2023

Ed Arce Reiterated (AKBA) at Strong Buy and Held Target at $3.75 on, Sep 27th, 2023


Published on 2024-10-28 06:36:24 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Reiterated "Akebia Therapeutics, Inc." (AKBA) at Strong Buy and Held Target at $3.75 on, Sep 27th, 2023.

Ed has made no other calls on AKBA in the last 4 months.



There is 1 other peer that has a rating on AKBA. Out of the 1 peers that are also analyzing AKBA, 0 agree with Ed's Rating of Hold.



This is the rating of the analyst that currently disagrees with Ed

  • Christopher Raymond of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $4 on, Wednesday, May 31st, 2023
Contributing Sources